GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma.

Front Oncol · 2022 · PMC9345608 · PMID 35928884

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

However, we nonetheless observed an overall trend that was consistent with the results of the analysis of grade II and III gliomas.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.